chr17-31304852-C-A

Variant summary

Our verdict is Benign. The variant received -16 ACMG points: 0P and 16B. BP4_StrongBP6_Very_StrongBS2

The NM_006495.4(EVI2B):​c.758G>T​(p.Cys253Phe) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000359 in 1,614,020 control chromosomes in the GnomAD database, including 3 homozygotes. In-silico tool predicts a benign outcome for this variant. 16/22 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).

Frequency

Genomes: 𝑓 0.0019 ( 2 hom., cov: 32)
Exomes 𝑓: 0.00020 ( 1 hom. )

Consequence

EVI2B
NM_006495.4 missense

Scores

1
18

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:2

Conservation

PhyloP100: -0.237

Publications

4 publications found
Variant links:
Genes affected
EVI2B (HGNC:3500): (ecotropic viral integration site 2B) Involved in positive regulation of granulocyte differentiation. Predicted to be integral component of plasma membrane. [provided by Alliance of Genome Resources, Apr 2022]
NF1 (HGNC:7765): (neurofibromin 1) This gene product appears to function as a negative regulator of the ras signal transduction pathway. Mutations in this gene have been linked to neurofibromatosis type 1, juvenile myelomonocytic leukemia and Watson syndrome. The mRNA for this gene is subject to RNA editing (CGA>UGA->Arg1306Term) resulting in premature translation termination. Alternatively spliced transcript variants encoding different isoforms have also been described for this gene. [provided by RefSeq, Jul 2008]
NF1 Gene-Disease associations (from GenCC):
  • neurofibromatosis type 1
    Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: Labcorp Genetics (formerly Invitae), ClinGen, PanelApp Australia, G2P, Genomics England PanelApp
  • neurofibromatosis-Noonan syndrome
    Inheritance: AD Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Orphanet, Genomics England PanelApp, PanelApp Australia
  • Moyamoya disease
    Inheritance: AD Classification: MODERATE Submitted by: Genomics England PanelApp
  • hereditary pheochromocytoma-paraganglioma
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • familial ovarian cancer
    Inheritance: AD Classification: NO_KNOWN Submitted by: ClinGen

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -16 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.004789889).
BP6
Variant 17-31304852-C-A is Benign according to our data. Variant chr17-31304852-C-A is described in ClinVar as Benign/Likely_benign. ClinVar VariationId is 446081.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS2
High Homozygotes in GnomAd4 at 2 AR gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
EVI2BNM_006495.4 linkc.758G>T p.Cys253Phe missense_variant Exon 2 of 2 ENST00000330927.5 NP_006486.3 P34910-1Q9BRW1
NF1NM_001042492.3 linkc.4836-20968C>A intron_variant Intron 36 of 57 ENST00000358273.9 NP_001035957.1 P21359-1
NF1NM_000267.4 linkc.4773-20968C>A intron_variant Intron 35 of 56 NP_000258.1 P21359-2

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
EVI2BENST00000330927.5 linkc.758G>T p.Cys253Phe missense_variant Exon 2 of 2 1 NM_006495.4 ENSP00000333779.4 P34910-1
NF1ENST00000358273.9 linkc.4836-20968C>A intron_variant Intron 36 of 57 1 NM_001042492.3 ENSP00000351015.4 P21359-1

Frequencies

GnomAD3 genomes
AF:
0.00191
AC:
290
AN:
152132
Hom.:
2
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.00672
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.000524
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.0000147
Gnomad OTH
AF:
0.00144
GnomAD2 exomes
AF:
0.000451
AC:
113
AN:
250736
AF XY:
0.000347
show subpopulations
Gnomad AFR exome
AF:
0.00605
Gnomad AMR exome
AF:
0.000347
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.00000883
Gnomad OTH exome
AF:
0.000328
GnomAD4 exome
AF:
0.000198
AC:
289
AN:
1461770
Hom.:
1
Cov.:
32
AF XY:
0.000173
AC XY:
126
AN XY:
727184
show subpopulations
African (AFR)
AF:
0.00684
AC:
229
AN:
33478
American (AMR)
AF:
0.000335
AC:
15
AN:
44722
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
26134
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39682
South Asian (SAS)
AF:
0.00
AC:
0
AN:
86250
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
53358
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
5766
European-Non Finnish (NFE)
AF:
0.0000189
AC:
21
AN:
1111990
Other (OTH)
AF:
0.000397
AC:
24
AN:
60390
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.486
Heterozygous variant carriers
0
19
39
58
78
97
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
10
20
30
40
50
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00191
AC:
291
AN:
152250
Hom.:
2
Cov.:
32
AF XY:
0.00191
AC XY:
142
AN XY:
74446
show subpopulations
African (AFR)
AF:
0.00672
AC:
279
AN:
41516
American (AMR)
AF:
0.000523
AC:
8
AN:
15298
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3470
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5186
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4832
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10608
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
0.0000147
AC:
1
AN:
68022
Other (OTH)
AF:
0.00142
AC:
3
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.494
Heterozygous variant carriers
0
14
28
42
56
70
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
10
20
30
40
50
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.000624
Hom.:
0
Bravo
AF:
0.00206
ESP6500AA
AF:
0.00613
AC:
27
ESP6500EA
AF:
0.00
AC:
0
ExAC
AF:
0.000585
AC:
71
Asia WGS
AF:
0.00115
AC:
4
AN:
3478

ClinVar

Significance: Benign/Likely benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:2
Jan 03, 2019
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Feb 27, 2017
Center for Pediatric Genomic Medicine, Children's Mercy Hospital and Clinics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.14
BayesDel_addAF
Benign
-0.50
T
BayesDel_noAF
Benign
-0.49
CADD
Benign
17
DANN
Benign
0.87
DEOGEN2
Benign
0.095
T;T
Eigen
Benign
-0.63
Eigen_PC
Benign
-0.64
FATHMM_MKL
Benign
0.035
N
LIST_S2
Benign
0.42
.;T
M_CAP
Benign
0.011
T
MetaRNN
Benign
0.0048
T;T
MetaSVM
Benign
-1.1
T
MutationAssessor
Benign
1.8
L;L
PhyloP100
-0.24
PrimateAI
Benign
0.46
T
PROVEAN
Pathogenic
-5.5
D;.
REVEL
Benign
0.040
Sift
Benign
0.24
T;.
Sift4G
Benign
0.88
T;T
Polyphen
0.21
B;B
Vest4
0.090
MVP
0.26
MPC
0.28
ClinPred
0.056
T
GERP RS
1.2
Varity_R
0.16
gMVP
0.081
Mutation Taster
=98/2
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs115271229; hg19: chr17-29631870; API